Global Influenza Programme
We provide Member States with strategic guidance, technical support and coordination of activities essential to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals.

 

Published 18 June 2025 | For reporting Week 23, ending 08 June 2025

Influenza

  • In the Southern hemisphere, influenza positivity continued to increase and was moderate to high (above 20%) in a few countries of Temperate South America (predominantly A(H1N1)pdm09). Influenza positivity was elevated (>10%) in countries of Tropical and Temperate South America (predominantly A(H1N1)pdm09), Southern Africa (predominantly A(H3N2)), Eastern Africa (predominantly A(H3N2)), South-East Asia (predominantly A(H3N2)) and Oceania (predominantly A(H1N1)pdm09).
  • In the Northern hemisphere, influenza activity remained stable or continued to decline in most countries with increases reported from a single country in Western Africa. Influenza positivity remained elevated in Central America and the Caribbean, Tropical South America and Western Africa (predominantly A(H1N1)pdm09), and Western, Southern and South-East Asia (predominantly A(H3N2)).
 

SARS-CoV-2

  • Globally, SARS-CoV-2 positivity remained stable and low across the majority of reporting countries. Positivity was elevated (>10%) in a few countries in Central America and the Caribbean, Tropical South America, Northern and South-West Europe and in Asia, with minor increases in activity reported in some countries.
 

Starting with report #501, the Global Respiratory Virus Activity Weekly Update included data from sentinel surveillance and other types of systematically conducted virologic surveillance. Countries, areas, and territories use a variety of approaches to monitor respiratory virus activity and data in this report may vary from surveillance reports posted elsewhere. Analyses stratified by source of surveillance is available through Respimart.